When ATH: N03AX16
Pharmacological action
Antiepileptics; subunit binds to more (a2-delta protein) voltage-dependent Ca2 -channels in the central nervous system, which contributes to the manifestation of analgesic and anticonvulsant action. Reducing the frequency of seizures started in the first week.
Pharmacokinetics
Всасывание натощак – быстрое, decreases in food intake. Bioavailability - approx. 90%, not dose. TCmax – 1 no (the single and repeated administration). TCSS (with repeated use) – 24-48 no. Food intake reduces Cmax by 25-30%, and increases to TCmax 2.5 no. Объем распределения – 0.56 l / kg. The pharmacokinetics in the range of the recommended daily dose is linear; interindividual variability less 20%; with repeated use pharmacokinetics predictable on the basis of a single dose of. It binds to plasma proteins, hardly metabolized (основной метаболит – N-метилированное производное прегабалина). There was no sign of racemization S-enantiomer of pregabalin the R-enantiomer. The plasma and renal clearance are directly proportional to creatinine clearance. After a 4-hour hemodialysis drug concentration in the plasma is reduced by 50%. The clearance of the drug in patients over 65 declining years, reflecting the age-related decline in creatinine clearance. T1/2 – 6.3 no. Excreted by the kidneys in unchanged form (98%) and an N-methylated derivative of pregabalin (0.9%).
Testimony
Neuropathic pain, epilepsy (in polytherapy), generalized anxiety disorder, fibromyalgia.
Contraindications
Hypersensitivity, childhood (to 17 years), lactation; dosage forms, содержащих лактозу – непереносимость галактозы, lactase deficiency Lapa, malabsorption of glucose / galactose.
C care
Renal failure, diabetes, pregnancy.
Dosage regimen
Inside, regardless of the meal, суточная доза – 150-600 mg, razdelennaya of 2-3 admission. Neuropathic pain: начальная доза – 150 mg / day; depending on the achieved effect and tolerability through 3-7 days to increase the dose 300 mg / day, if necessary, even through 7 дней – до максимальной дозы 600 mg / day. In epilepsy: начальная доза – 150 mg / day; depending on the achieved effect and tolerability through 7 days to increase the dose 300 mg / day, through 7 дней – до максимальной дозы 600 mg / day. In renal insufficiency, the daily dose is chosen based on creatinine clearance: creatinine clearance 60 мл/мин и более начальная доза – 150 mg / day, максимальная – 600 mg / day, кратность приема – 2-3 times; creatinine clearance 30-60 ml / min, initial dose - 75 mg / day, максимальная – 300 mg / day, the multiplicity of reception 2-3 times; creatinine clearance 15-30 ml / min, initial dose - 25-50 mg / day, максимальная – 150 mg / day, the multiplicity of reception 1-2 times; creatinine clearance less than 15 ml / min, initial dose - 25 mg / day, the maximum dose - 75 mg / day, кратность приема – 1 time. With hemodialysis, after each 4-hour session, назначают дополнительную начальную дозу – 25 mg / day, максимально – 100 mg / day one. Patients over 65 s may require dose reduction due to the decrease in renal function. Treatment stopped gradually for at least 1 of the week. When fibromyalgia daily dose is 300 to 600 mg.
Side effects
Frequency: very frequent (more 1/10), frequent (more 1/100 less 1/10), infrequent (more 1/1 000 less 1/100), few (less 1/1000).
From the nervous system: очень частые – головокружение, drowsiness; частые – атаксия, impaired concentration, coordination, memory impairment, tremor, dysarthria, paraesthesia, euphoria, confusion, decreased libido, irritability; нечастые – когнитивные расстройства, gipesteziya, violation of the visual fields, nistagmo, dysarthria, myoclonic seizures, weakening of reflexes, dyskinesia, psychomotor hyperactivity, dizziness upright, gipersteziya, loss of taste, burning sensation on the skin and mucous membranes, intention tremor, stupor, fainting, depersonalization, anorgazmija, anxiety, depression, ažitaciâ, mood lability, strengthening of insomnia, dejection, difficulties in finding words, hallucinations, unusual dreams, increased libido, panic attacks, apathy; редко – гипокинез, parosmija, chirospasm, disinhibition, high spirits.
From the senses: frequent - blurred vision, diplopia; нечастые – снижение остроты зрения, sore eyes, asthenopia, dryness of mucous membranes of the eyes, eye puffiness, increased lacrimation; редкие – мелькание искр перед глазами, eye irritation, midriaz, oscillopsia (subjective feeling vibrations considered subjects), violation of depth perception, the loss of peripheral vision, kosoglazie, Brightness enhancement of visual perception, hyperacusis.
Cardio-vascular system: нечастые – тахикардия, "Tides"; редкие – AV блокада I ст., sinus tachycardia, sinus arrhythmia, sinusovaya bradycardia, decrease or increase in blood pressure, cold extremities.
The respiratory system: нечастые – одышка, dryness of the nasal mucosa; редкие – назофарингит, cough, nasal congestion, nose bleed, rhinitis, snoring, a sense of "tightness" in the throat.
From the digestive system: частые – сухость во рту, increased appetite, vomiting, constipation, flatulence; нечастые – гиперсаливация, hastroэzofahealnыy reflux, desensitization in the oral cavity, anorexia; редкие – асцит, dysphagia, pancreatitis.
From the side of hematopoiesis: редкие – нейтропения.
With the genitourinary system: частые – эректильная дисфункция; нечастые – дизурия, urinary incontinence, delayed ejaculation, sexual dysfunction; редкие – олигурия, renal failure, menorrhea, breast pain, discharge from the breast, dysmenorrhoea, hypertrophy breast.
On the part of the musculoskeletal system: нечастые – подергивания мышц, swelling of joints, constraint, muscle cramps, myalgia, arthralgia, backache, pain in the extremities; редкие – спазм шейных мышц, neck pain, raʙdomioliz.
Other: частые – утомляемость, peripheral and generalized edema, feeling "intoxicated", gait disturbance; нечастые – астения, thirst, chest tightness, increase or reduction of body weight, Sweating, papulleznaya rash; редкие – холодный пот, hives, increased pain when Anasarca, fever, chills.
Laboratory findings: нечастые – повышение активности аланинаминотрансферазы, aspartate aminotransferase, creatine, thrombocytopenia; редкие – гипергликемия, gipoglikemiâ, giperkreatininemiя, kaliopenia, leukopenia.
Side effects with postmarketing surveillance: со стороны нервной системы – головная боль. From the digestive system: редко – отек языка, nausea. For the skin: редко – отек лица.
Overdose
Treatment: gastric lavage, simptomaticheskaya therapy, hemodialysis.
Cautions
In diabetes (in the case of weight gain on a background of pregabalin) a correction dose hypoglycemic drugs. Treatment may be accompanied by dizziness, sleepiness, that increase the risk of injuries in the elderly. Information about the possible cancellation of others. anticonvulsant drugs and feasibility alone is not enough pregabalin. When pregnancy is used only in the event, if the expected benefit to the mother outweighs the risk to the fetus. During treatment, women of childbearing age should use reliable methods of contraception. During the period of treatment should refrain from driving vehicles and Occupation potentially hazardous activities, require high concentration and speed of psychomotor reactions.
Drug Interactions
There were no pharmacokinetic interaction with phenytoin, karʙamazepinom, valproic acid, lamotrigine, Gabapentin, lorazepam, oxycodone, ethanol. Oral hypoglycemic drugs, Diuretic, insulin, phenobarbital, tiagaʙin, Topiramate did not affect the clearance of pregabalin. When using oral contraceptives, containing norethisterone and / or ethinyl estradiol, simultaneously with pregabalin pharmacokinetics of both drugs remained unchanged. Reapply with oxycodone, lorazepam, ethanol has no clinically significant effect on respiration. Pregabalin, probably, enhances cognitive disorders and motor functions, caused by oxycodone. Pregabalin may potentiate the effects of ethanol and lorazepam.
This site uses cookies and services to collect technical data from visitors to ensure performance and improve the quality of service.. By continuing to use our site, you automatically agree to the use of these technologies.
Read More